• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 腺苷脱氨酶作用下的可变剪接的全球调控(ADAR)。

Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).

机构信息

Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Ramat Gan, Israel.

出版信息

RNA. 2013 May;19(5):591-604. doi: 10.1261/rna.038042.112. Epub 2013 Mar 8.

DOI:10.1261/rna.038042.112
PMID:23474544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3677275/
Abstract

Alternative mRNA splicing is a major mechanism for gene regulation and transcriptome diversity. Despite the extent of the phenomenon, the regulation and specificity of the splicing machinery are only partially understood. Adenosine-to-inosine (A-to-I) RNA editing of pre-mRNA by ADAR enzymes has been linked to splicing regulation in several cases. Here we used bioinformatics approaches, RNA-seq and exon-specific microarray of ADAR knockdown cells to globally examine how ADAR and its A-to-I RNA editing activity influence alternative mRNA splicing. Although A-to-I RNA editing only rarely targets canonical splicing acceptor, donor, and branch sites, it was found to affect splicing regulatory elements (SREs) within exons. Cassette exons were found to be significantly enriched with A-to-I RNA editing sites compared with constitutive exons. RNA-seq and exon-specific microarray revealed that ADAR knockdown in hepatocarcinoma and myelogenous leukemia cell lines leads to global changes in gene expression, with hundreds of genes changing their splicing patterns in both cell lines. This global change in splicing pattern cannot be explained by putative editing sites alone. Genes showing significant changes in their splicing pattern are frequently involved in RNA processing and splicing activity. Analysis of recently published RNA-seq data from glioblastoma cell lines showed similar results. Our global analysis reveals that ADAR plays a major role in splicing regulation. Although direct editing of the splicing motifs does occur, we suggest it is not likely to be the primary mechanism for ADAR-mediated regulation of alternative splicing. Rather, this regulation is achieved by modulating trans-acting factors involved in the splicing machinery.

摘要

选择性剪接是基因调控和转录组多样性的主要机制。尽管这种现象的程度很大,但剪接机制的调节和特异性仅部分得到理解。ADAR 酶对前体 mRNA 的腺苷到肌苷(A-to-I)RNA 编辑已在几种情况下与剪接调节相关。在这里,我们使用生物信息学方法、ADAR 敲低细胞的 RNA-seq 和外显子特异性微阵列,全面研究了 ADAR 及其 A-to-I RNA 编辑活性如何影响选择性 mRNA 剪接。尽管 A-to-I RNA 编辑很少靶向典型的剪接接受体、供体和分支位点,但它被发现影响外显子内的剪接调节元件(SRE)。与组成型外显子相比,盒式外显子被发现含有显著更多的 A-to-I RNA 编辑位点。RNA-seq 和外显子特异性微阵列显示,肝癌和髓样白血病细胞系中 ADAR 的敲低导致基因表达的全局变化,数百个基因在两种细胞系中改变了它们的剪接模式。这种剪接模式的全局变化不能仅用潜在的编辑位点来解释。显示剪接模式显著变化的基因通常涉及 RNA 处理和剪接活性。对最近发表的胶质母细胞瘤细胞系的 RNA-seq 数据进行分析显示了类似的结果。我们的全局分析表明,ADAR 在剪接调节中发挥主要作用。尽管确实发生了对剪接基序的直接编辑,但我们认为这不太可能是 ADAR 介导的选择性剪接调节的主要机制。相反,这种调节是通过调节参与剪接机制的反式作用因子来实现的。

相似文献

1
Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).RNA 腺苷脱氨酶作用下的可变剪接的全球调控(ADAR)。
RNA. 2013 May;19(5):591-604. doi: 10.1261/rna.038042.112. Epub 2013 Mar 8.
2
Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.ADAR2异常的可变剪接模式下调胶质瘤中腺苷到肌苷的编辑。
Oncol Rep. 2015 Jun;33(6):2845-52. doi: 10.3892/or.2015.3907. Epub 2015 Apr 8.
3
Adenosine to Inosine editing frequency controlled by splicing efficiency.由剪接效率控制的腺苷到肌苷的编辑频率。
Nucleic Acids Res. 2016 Jul 27;44(13):6398-408. doi: 10.1093/nar/gkw325. Epub 2016 Apr 25.
4
ADAR-mediated RNA editing in non-coding RNA sequences.ADAR 介导的非编码 RNA 序列中的 RNA 编辑。
Sci China Life Sci. 2013 Oct;56(10):944-52. doi: 10.1007/s11427-013-4546-5. Epub 2013 Sep 5.
5
ADAR-deficiency perturbs the global splicing landscape in mouse tissues.ADAR 缺陷扰乱了小鼠组织中的全局剪接景观。
Genome Res. 2020 Aug;30(8):1107-1118. doi: 10.1101/gr.256933.119. Epub 2020 Jul 29.
6
Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.大规模预测 ADAR 介导的有效的人类 A-to-I RNA 编辑。
Brief Bioinform. 2019 Jan 18;20(1):102-109. doi: 10.1093/bib/bbx092.
7
A high resolution A-to-I editing map in the mouse identifies editing events controlled by pre-mRNA splicing.在小鼠中高分辨率的 A-to-I 编辑图谱鉴定了由前体 mRNA 剪接控制的编辑事件。
Genome Res. 2019 Sep;29(9):1453-1463. doi: 10.1101/gr.242636.118. Epub 2019 Aug 19.
8
In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.在癌症中,A-to-I RNA 编辑可能是驱动因素、乘客或机制。
Drug Resist Updat. 2017 May;32:16-22. doi: 10.1016/j.drup.2017.09.001. Epub 2017 Oct 4.
9
Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.腺苷到肌苷 RNA 编辑酶 ADAR 和 microRNAs。
Methods Mol Biol. 2021;2181:83-95. doi: 10.1007/978-1-0716-0787-9_6.
10
To edit or not to edit: regulation of ADAR editing specificity and efficiency.编辑与否:ADAR 编辑特异性与效率的调控
Wiley Interdiscip Rev RNA. 2016 Jan-Feb;7(1):113-27. doi: 10.1002/wrna.1319. Epub 2015 Nov 26.

引用本文的文献

1
ADARs: pleiotropy in function, versatility in application.腺苷脱氨酶作用于RNA(ADARs):功能上的多效性,应用上的多样性。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf672.
2
Emerging clinical applications of ADAR based RNA editing.基于ADAR的RNA编辑的新兴临床应用。
Stem Cells Transl Med. 2025 May 19;14(5). doi: 10.1093/stcltm/szaf016.
3
Zα and Zβ Localize ADAR1 to Flipons That Modulate Innate Immunity, Alternative Splicing, and Nonsynonymous RNA Editing.Zα和Zβ将ADAR1定位于可调节先天免疫、可变剪接和非同义RNA编辑的Flipons上。
Int J Mol Sci. 2025 Mar 7;26(6):2422. doi: 10.3390/ijms26062422.
4
RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders.由人工智能驱动的RNA编辑特征:区分精神分裂症、双相情感障碍和分裂情感性障碍的新前沿。
Int J Mol Sci. 2024 Dec 3;25(23):12981. doi: 10.3390/ijms252312981.
5
Distinct interactomes of ADAR1 nuclear and cytoplasmic protein isoforms and their responses to interferon induction.ADAR1核蛋白和胞质蛋白亚型的不同相互作用组及其对干扰素诱导的反应。
Nucleic Acids Res. 2024 Dec 11;52(22):14184-14204. doi: 10.1093/nar/gkae1106.
6
Structural perspectives on adenosine to inosine RNA editing by ADARs.ADAR介导的腺苷到肌苷RNA编辑的结构视角。
Mol Ther Nucleic Acids. 2024 Jul 19;35(3):102284. doi: 10.1016/j.omtn.2024.102284. eCollection 2024 Sep 10.
7
Reovirus infection induces transcriptome-wide unique A-to-I editing changes in the murine fibroblasts.呼肠孤病毒感染诱导鼠成纤维细胞中转录组范围独特的 A 到 I 编辑变化。
Virus Res. 2024 Aug;346:199413. doi: 10.1016/j.virusres.2024.199413. Epub 2024 Jun 13.
8
RNA Pol II-dependent transcription efficiency fine-tunes A-to-I editing levels.RNA Pol II 依赖性转录效率精细调节 A-to-I 编辑水平。
Genome Res. 2024 Mar 20;34(2):231-242. doi: 10.1101/gr.277686.123.
9
Cooperation and Competition of RNA Secondary Structure and RNA-Protein Interactions in the Regulation of Alternative Splicing.RNA二级结构与RNA-蛋白质相互作用在可变剪接调控中的协同与竞争
Acta Naturae. 2023 Oct-Dec;15(4):23-31. doi: 10.32607/actanaturae.26826.
10
Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.利用 ADAR 介导的免疫相关疾病特异性 RNA 编辑:预测和治疗意义。
Int J Mol Sci. 2023 Dec 26;25(1):351. doi: 10.3390/ijms25010351.

本文引用的文献

1
ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.ADAR1 促进慢性髓性白血病恶性祖细胞重编程。
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):1041-6. doi: 10.1073/pnas.1213021110. Epub 2012 Dec 28.
2
Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice.RNA 编辑酶 ADAR1 的缺失可导致小鼠已建立的慢性髓系白血病消退。
Int J Cancer. 2013 Apr 15;132(8):1741-50. doi: 10.1002/ijc.27851. Epub 2012 Oct 17.
3
Detecting differential usage of exons from RNA-seq data.从 RNA-seq 数据中检测外显子的差异使用。
Genome Res. 2012 Oct;22(10):2008-17. doi: 10.1101/gr.133744.111. Epub 2012 Jun 21.
4
Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins.整合全基因组分析揭示 hnRNP 蛋白对可变剪接的协同调控作用。
Cell Rep. 2012 Feb 23;1(2):167-78. doi: 10.1016/j.celrep.2012.02.001.
5
Accurate identification of human Alu and non-Alu RNA editing sites.准确识别人类 Alu 与非 Alu RNA 编辑位点。
Nat Methods. 2012 Jun;9(6):579-81. doi: 10.1038/nmeth.1982. Epub 2012 Apr 4.
6
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.癌症细胞系百科全书使对抗癌药物敏感性的预测建模成为可能。
Nature. 2012 Mar 28;483(7391):603-7. doi: 10.1038/nature11003.
7
Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome.全面分析 RNA-Seq 数据揭示了人类转录组中广泛的 RNA 编辑。
Nat Biotechnol. 2012 Feb 12;30(3):253-60. doi: 10.1038/nbt.2122.
8
Evolutionarily conserved A-to-I editing increases protein stability of the alternative splicing factor Nova1.进化上保守的 A-to-I 编辑增加了可变剪接因子 Nova1 的蛋白质稳定性。
RNA Biol. 2012 Jan;9(1):12-21. doi: 10.4161/rna.9.1.18387. Epub 2012 Jan 1.
9
Evidence for widespread association of mammalian splicing and conserved long-range RNA structures.哺乳动物剪接和保守的长距离 RNA 结构广泛关联的证据。
RNA. 2012 Jan;18(1):1-15. doi: 10.1261/rna.029249.111. Epub 2011 Nov 29.
10
Identification and correction of systematic error in high-throughput sequence data.高通量测序数据中系统误差的识别与校正。
BMC Bioinformatics. 2011 Nov 21;12:451. doi: 10.1186/1471-2105-12-451.